Site records / India / FEI 3004483648

Resonance Laboratories Private LimitedBengaluru

FDA-registered drug establishment in Bengaluru: api manufacture. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.

Inspections posted: 2
Last inspection: Feb 2025 · VAI
Warning letters to this FEI: 1
Import alerts at this address: 0
US border refusals, 2 years: 0

The site dossier

This site, graded.
Every fact sourced.

A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
Warning-letter violations, numbered and labelled
Import-alert history rebuilt from the archive, each listing checked against this address
Border refusals by product, and the company's other sites, each graded
A hash of every source read, so the PDF can be checked against the record

On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.

PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.

By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.

Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan

Inspections

2 FDA inspections of this FEI, by end date; 2 with a posted classification.

7 Feb 2025VAI · Voluntary Action IndicatedDrug Quality Assurance · no citations posted
6 May 2016OAI · Official Action IndicatedDrug Quality Assurance · no citations posted

Warning letters and compliance actions

3 Feb 2017Warning Letter · CDER

Import alerts in force

No listing in force under this firm's name.

Registration

FEI: 3004483648
DUNS: 918316485
Registered as: RESONANCE LABORATORIES PRIVATE LIMITED
Registrant: RESONANCE LABORATORIES PRIVATE LIMITED
Address: Plot No. 8C & 9A, KIADB Industrial Area, Bashettihalli, Doddaballapur, Bengaluru, KA 561203, India (IND)
Operations: API MANUFACTURE
Registration expires: 31 Dec 2026

Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.